Event Details
Accelerate your cell and gene therapy programs with expert insights
Aldevron provides comprehensive solutions for genomic medicine pioneers across multiple modalities. At the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting, we invite you to attend our highly focused Knowledge Lab sessions.
Our scientific team will share precise, technical insights to help you navigate complex development challenges. These structured discussions highlight the latest advancements in cell and gene therapy, empowering you to advance your therapeutic projects with confidence.
Lunch will be provided. Registration is limited on a first-come, first-served basis, so we encourage you to secure your seat early.
Not attending ASGCT? Register below to receive a recording after the conference.
Tuesday, May 12 | 12 – 1:15 PM
Advancing mRNA Manufacturing With Alchemy™: Next-Generation Cell-Free DNA Solutions for Speed, Quality, and Scalability
The production of next-generation mRNA therapeutics requires rapid, efficient, and high-fidelity cell-free template DNA solutions. Aldevron’s Alchemy platform is engineered to meet these demands, delivering template DNA that ensures unmatched quality and scalability. This session will detail how our technology facilitates successful downstream applications and supports groundbreaking therapeutic advancements.
- Speaker: Nate Russart
- Date: Tuesday, May 12, 2026
- Time: 12 – 1:15 PM
- Location: Room 213
Wednesday, May 13 | 12 – 1:15 PM
From Design to Delivery: A Translational Framework for Non-Viral Gene Editing
Advancing non-viral CRISPR-mediated gene editing from concept to clinical application requires a seamless and robust workflow. This process demands careful consideration of specificity, manufacturability, and regulatory compliance to ensure therapeutic success. In this session, our experts will explore a comprehensive, end-to-end framework designed to support both in vivo and ex vivo genomic medicine applications. We will demonstrate how our integrated approach, which includes guide RNA (gRNA), off-target analysis, nucleases, Nanoplasmid™ vectors, and other gene editing tools, ensures your cell and gene therapies meet the highest standards at every stage of development.
- Speakers: Max Sellman (Aldevron) and Ashley Jacobi (Integrated DNA Technologies)
- Date: Wednesday, May 13, 2026
- Time: 12 – 1:15 PM
- Location: Room 213
Register to Our Knowledge Lab Sessions
| region | na1 |
| portalId | 1769030 |
| formId | 32bcecde-e0d3-40d5-a259-e637204e203d |
| target | services-hubspot-form |